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ttp://dx.doi.org/10.1016/j.ajpath.2014.05.024Cholesterol elimination from nonhepatic cells involves metabolism to side-chain oxysterols, which serve
as transport forms of cholesterol and bioactive molecules modulating a variety of cellular processes.
Cholesterol metabolism is tissue speciﬁc, and its signiﬁcance has not yet been established for the retina,
where cytochromes P450 (CYP27A1 and CYP46A1) are the major cholesterol-metabolizing enzymes. We
generated Cyp27a1/Cyp46a1/ mice, which were lean and had normal serum cholesterol and glucose
levels. These animals, however, had changes in the retinal vasculature, retina, and several nonocular
organs (lungs, liver, and spleen). Changes in the retinal vasculature included structural abnormalities
(retinal-choroidal anastomoses, arteriovenous shunts, increased permeability, dilation, nonperfusion,
and capillary degeneration) and cholesterol deposition and oxidation in the vascular wall, which also
exhibited increased adhesion of leukocytes and activation of the complement pathway. Changes in the
retina included increased content of cholesterol and its metabolite, cholestanol, which were focally
deposited at the apical and basal sides of the retinal pigment epithelium. Retinal macrophages of
Cyp27a1/Cyp46a1/mice were activated, and oxidative stress was noted in their photoreceptor inner
segments. Our ﬁndings demonstrate the importance of retinal cholesterol metabolism for maintenance of
the normal retina, and suggest new targets for diseases affecting the retinal vasculature. (Am J Pathol
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Medical Center, the Ohio State University, Columbus, OH.Cholesterol maintenance in the retina is still poorly under-
stood, perhaps because of cellular and laminar complexity
of the retina and unique functions related to photo-
transduction and transmission of the visual signal.1,2 The
sources of retinal cholesterol have been established, how-
ever, and include local synthesis as well as uptake from the
systemic circulation across the blood-retina barrier.3e5 The
mechanisms for cholesterol elimination have also been
elucidated, and involve lipoprotein-mediated transport1 and
enzymatic processing by different cytochrome P450 (CYP)
enzymes.6e12 The daily process of photoreceptor (PR)
phagocytosis represents an additional pathway of retinal
cholesterol removal.13 Nevertheless, the quantitative sig-
niﬁcance, coordination, and role of the different pathways
for retinal cholesterol input and output remain unclear.stigative Pathology.
.We focused on CYP27A1 and CYP46A1 because these
enzymes are responsible for most of the cholesterol meta-
bolism in the retina.8e11 Both use cholesterol as a substrate
but generate different products: 27-hydroxycholesterol and
5-cholestanoic acid (CYP27A1) or 24S-hydroxycholesterol
Saadane et al(CYP46A1).10 Hydroxylation makes cholesterol more solu-
ble and, thus, able to spontaneously diffuse out of cells into
the circulation.14 Accordingly, side-chain oxysterols repre-
sent the forms of cholesterol in which excess tissue choles-
terol is transported to the liver for further degradation to bile
acids. In addition, 27-hydroxycholesterol, 5-cholestanoic
acid, and 24S-hydroxycholesterol could play regulatory
roles by interacting with different proteins. Oxysterols can
bind to the insulin-induced gene protein and 3-hydroxy-3-
methyl-glutaryl-CoA reductase and thereby regulate cho-
lesterol biosynthesis.15 Oxysterols can also activate
transcription factors of the liver X receptor (LXR)
family16e18 and thereby control cholesterol removal by li-
poproteins. Collectively, through interactions with different
proteins, oxysterols couple three pathways of cellular
cholesterol homeostasis: cholesterol biosynthesis, cholesterol
metabolism, and elimination by lipoproteins. In addition, by
activating LXRs, oxysterols participate in the regulation of
fatty acid and triglyceride biosynthesis, glucose metabolism,
and immune-inﬂammatory responses.17,19 The afﬁnity of
oxysterols for LXRs depends on their structure, and LXR-
mediated gene activation is tissue and gene speciﬁc.20e22
We recently reported that mice lacking CYP27A1 develop
retinal-choroidal anastomoses (RCAs) characteristic of age-
related macular degeneration (AMD) type 3, and that these
lesions are associated with focal cholesterol-containing de-
posits along Bruch’s membrane.12 Herein, we generatedmice
that lack both CYP27A1 and CYP46A1. CYP27A1 is found
in almost every cell in the retina and is highly expressed in the
inner segments (ISs), Müller cells, and retinal pigment
epithelium (RPE).6,13 Retinal distribution of CYP46A1 is
more restricted and limited to the ganglion cell layer (GCL),
inner plexiformeinner nuclear layer (INL) interface, and the
RPE.7,13,23 Outside the retina, CYP27A1 is ubiquitous and
particularly abundant in the liver, vascular endothelium, and
macrophages, especially lung macrophages.24e27 Nonocular
expression of CYP46A1 is limited to the brain,28 where
CYP46A1 is present at levels approximately 7 higher than
those in the retina.9We hypothesized that the retina may have
a more severe phenotype than that of Cyp27a1/ mice if
both CYP27A1 and CYP46A1 were ablated, because this
model would have a greater impact on retinal cholesterol
metabolism and the production of the regulatory side-chain
oxysterols. The latter could be particularly important: in
addition to oxysterols produced intracellularly, each retinal
cell type is exposed to oxysterols generated by other cell
types, and may uptake these preformed oxysterols during
their diffusion to the intraretinal and choroidal vascular net-
works that supply blood to the inner and outer retina,
respectively. Endothelial cells of the intraretinal capillaries
do not have circular openings (fenestrae) in their wall and are
exposed to a slower rate of blood ﬂow compared with
choroidal vessels, which have fenestrae that face the retina.
Hence, retina-generated oxysterols probably have a slower
diffusion rate across the wall of the intraretinal capillaries
than of the choriocapillaris. Coupled with high expression of2404CYP27A1 in vascular endothelium,25 these peculiarities of
the retina suggest that retinal vasculature is exposed to rela-
tively high levels of oxysterols and should be sensitive to the
lack of oxysterol production. Consistent with our expecta-
tions, a wide variety of retinal vascular lesions were found in
Cyp27a1/Cyp46a1/ mice, with some being similar to
those characteristic of type 3 neovascular AMD and some
typical of early-stage diabetic retinopathy. As reported
herein, the retina, as well as some nonocular organs, cannot
compensate for a simultaneous lack of CYP27A1 and
CYP46A1, and develops pathological features that reﬂect the
tissue response to cholesterol overload and impaired oxy-
sterol production. The present work expands our knowledge
of retinal abnormalities associated with disturbed cholesterol
metabolism, and suggests that molecules mimicking a regu-
latory function of oxysterols (namely, agonists of LXRs)
should be considered for the treatment of AMD and diabetic
retinopathy.
Materials and Methods
Animals
Cyp27a1þ/ mice on the C57BL/6J background29 and
Cyp46a1/ mice on the mixed C57BL/6J;129S6/SvEv
background30 were obtained from the laboratory of Dr. Sandra
Erickson (University of California, San Francisco, San Fran-
cisco, CA) and Dr. David Russell (University of Texas
Southwestern, Dallas, TX), respectively. These animals were
bred to generateCyp27a1/Cyp46a1/ line andCyp27a1þ/þ
Cyp46a1þ/þ littermates. F5 and subsequent generations of
Cyp27a1/Cyp46a1/ and Cyp27a1þ/þCyp46a1þ/þ mice
were used for all experiments. Animals were aged 3 to 6
months, unless otherwise indicated. Mice were maintained on a
standard 12-hour light (approximately 10 lux)edark cycle and
were fed standard rodent chow and water ad libitum. All animal
procedures were approved by the Case Western Reserve Uni-
versity (Cleveland, OH) Institutional Animal Care and Use
Committee and conformed to recommendations of the Amer-
ican Veterinary Association Panel on Euthanasia and the As-
sociation for Research in Vision and Ophthalmology.
Sterol Quantiﬁcations
Mice were anesthetized with 80 mg/kg ketamine and 15 mg/
kg xylazine in phosphate-buffered saline (PBS) and sacri-
ﬁced by cervical dislocation. The eyes were enucleated, the
anterior segment was removed, and the lens with the vitre-
ous humor was squeezed out of the eye cup. The retina/RPE
was carefully scooped with a microspatula and dipped
quickly 3 in PBS. Samples of the washed retina/RPE from
40 animals of the same sex and genotype were combined,
and the pooled sample was homogenized as described.10
The homogenate was divided into three portions, each
processed separately for sterol content determination by
isotope dilution gas chromatographyemass spectrometry, asajp.amjpathol.org - The American Journal of Pathology
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males and females. The analyses used unsaponiﬁed retinal
extracts as sterols, mainly unesteriﬁed in the retina, and
some of them (eg, pregnenolone and 7-ketocholesterol)
decompose during the saponiﬁcation step needed to measure
total (unesteriﬁed plus esteriﬁed) sterol content.10 Choles-
terol was the only sterol for which unesteriﬁed and total
amounts were measured. The measurements of cholestanol
were based on [2H4]lathosterol as internal standard and used
the 215 m/z ion for cholestanol and 259 m/z ion for [2H4]
lathosterol.
Retinal Imaging and Function
Ultraehigh-resolution spectral-domain optical coherence to-
mography (SD-OCT), ﬂuorescein angiography (FA), trans-
mission electron microscopy (TEM), and electroretinographic
(ERG) recordings were as described.12,31 We used the
840HHP SD-OCT system (Bioptigen, Durham, NC), a scan-
ning laser ophthalmoscope (Spectralis HRAþOCT; Heidel-
berg Engineering, Carlsbad, CA), a 1200EX transmission
electron microscope (JEOL Ltd, Peabody, MA), and a Uni-
versal Testing and Electrophysiological System UTAS
E-3000 (LKC Technologies Inc., Gaithersburg, MD), respec-
tively. For electroretinography, mice were dark adapted
overnight and then anesthetized with 80 mg/kg ketamine and
15 mg/kg xylazine in PBS via i.p. injection. The pupils were
dilated with 1% tropicamide eye drops. ERGs were recorded
using a contact lens electrode placed on each cornea. Needle
electrodes placed in the scalp and tail were used as reference
and ground, respectively. White strobe ﬂashes were presented
to the dark-adapted eye in order of increasing stimulus strength
(from3.7 to 2.1 log cd$s/m2). At each stimulus level, three to
ﬁve responses were averaged, and interstimulus intervals
ranged from 10 seconds to 1 minute for the highest ﬂash
stimuli. After 7 minutes of adaptation to a steady background
(150 cd/m2), light-adapted, cone-mediated ERGs were recor-
ded in response to strobe stimuli superimposed on the back-
ground. The a-wave amplitudewasmeasured at 7milliseconds
after ﬂash presentation from the prestimulus baseline. The
amplitude of the b-wave was measured from the a-wave
minimum to the b-wave maximum.
The preparation of retinal and aortic root sections, ﬂat
mounts, elastase digests, and histological stains with oil red O,
ﬁlipin, tomato lectin, and antibodies against iso[4]LGE2
were as previously described.12,31e33 Immunostaining for
iso[4]LGE2 adducts required pretreatment with phospholi-
pase A2 (PLA2) to cleave the carboxylate ester and increase
immunoreactivity. This was performed as described31 by
placing retinal sections in 200 U/mL PLA2-containing digest
buffer (25 mmol/L Tris-Cl, pH 7.5, containing 10 mmol/L
CaCl2, 100 mmol/L KCl, 100 mg/mL butylated hydrox-
ytoluene, and 0.02% Triton X-100) for 1 hour at 37C.
Slides were then washed 3 for 5 minutes in PBS con-
taining 0.05% Tween 20 (PBS-Tween), extracted with 70%
ethanol in water for 5 minutes, and washed again 3 withThe American Journal of Pathology - ajp.amjpathol.orgPBS-Tween. Sections were blocked for 1 hour with 5%
nonimmunized goat serum (Invitrogen, Grand Island, NY)
in PBS-Tween (blocking buffer) and incubated overnight at
4C with iso[4]LGE2 antiserum or nonimmunized rabbit
serum (dilution, 1:2500 in blocking buffer). Next morning,
slides were washed 3 for 5 minutes in PBS-Tween and
incubated for 1 hour in dark with DyLight 649econjugated
goat anti-rabbit IgG (Jackson ImmunoResearch, West Grove,
PA), diluted 1:200 in blocking buffer. Slides were washed 3
with PBS-Tween, then 2 with water, blotted dry, and
mounted with ProLong Gold with DAPI (Invitrogen) and a
glass coverslip. For other immunostaining, PLA2 digest was
omitted and the dilution and source of primary antibodies
were 1:1000 for rabbit antieionized calcium binding adaptor
molecule 1 (Iba1; Wako, Richmond, VA), 1:100 for rat anti-
F4/80 (AbDSerotec, Raleigh, NC), 1:200 for mouse antie7-
ketocholesterol (JaICA, Fukuroi, Japan), 1:50 for mouse
anti-CD11b (Hycult Biotech, Plymouth Meeting, PA), and
1:50 for mouse anti-complement factors complement protein
3 (C3)/cleavage product 3a (C3a) and C9 (Hycult Biotech).
Anti-Iba1 and anti-F4/80 were visualized with goat anti-rabbit
DyLight 649 secondary antibodies (Jackson ImmunoR-
esearch) and anti-rat IgG Alexa Fluor 647 (Cell Signaling,
Danvers, MA), respectively, used at a 1:200 dilution. The
detection of primary antibodies from mice was by the Mouse
on Mouse Elite Peroxidase Kit (Vector Laboratories, Burlin-
game, CA) and used ImmPACT VIP Peroxidase Substrate
(Vector Laboratories). Slides were imaged on an inverted
microscope (model DMI 6000B; LeicaMicrosystems) using a
Retiga EXi-Fast camera (QImaging, Surrey, BC, Canada).
Histological quantiﬁcations of staining with oil red O and
antibodies against Iba1, CD11b, complement factors C3/C3a
and C9, iso[4]LGE2, and 7-ketocholesterol were performed in
Metamorph software (Molecular Devices Corp., Sunnyvale,
CA), with an equal area of retinas being examined for all
images. Positive staining was identiﬁed and recorded as a
percentage of the area examined.
PCR Arrays and RT-qPCR
Retinas from four mice per genotype were combined, and total
RNA was isolated by the TRIzol Reagent (Life Technologies,
Grand Island, NY). Total RNA (1 mg) was then converted to
cDNA by SuperScript III Reverse Transcriptase (Invitrogen)
and used for gene proﬁling by the lipoprotein signaling and
cholesterol metabolism and angiogenesis PCR arrays
(SABiosciences, Valencia, CA). PCR arrays were run in the
Mastercycler RealPlex2 machine (Eppendorf, Hauppauge,
NY). Changes between the genotypes in gene expression were
calculated, as described,13 after normalization to the ﬁve
housekeeping genes (glucuronidase b, hypoxanthine guanine
phosphoribosyl transferase 1, heat shock protein 90a class B
member, glyceraldehyde-3-phosphate dehydrogenase, and b-
actin). Subsequent validation of gene expression by quantita-
tive RT-PCR (RT-qPCR) was performed using the primers
that were designed and assessed, as described,13 with the PCRs2405
Saadane et albeing performed in triplicate and normalized to b-actin. The
message levels for Abcg1 in the lungs were assessed in indi-
vidual animals (nZ 3 forCyp27a1/Cyp46a1/mice; nZ
4 for Cyp27a1þ/þCyp46a1þ/þ littermates) and then averaged.
Measurement of Liver Triglycerides
Lipids from liver homogenates (15%, w/v) were extracted
with 19 volumes of chloroform/methanol (2:1, v/v), dried,
and saponiﬁed overnight in 1N KOH/70% aqueous ethanol
at 55C. Glycerol content was measured after sample
neutralization with MgCl2 using the Free Glycerol Reagent
kit (Sigma-Aldrich, St. Louis, MO), according to the man-
ufacturer’s protocol.
Serum Chemistry and Glucose Tolerance
Blood (5 to 10 mL) was withdrawn from the tail vein of mice
fasted overnight and assayed for glucose and hemoglobin A1c
levels by anEliteXLGlucometer (Bayer Contour,Whippany,
NJ) and VARIANT II kit (Bio-Rad, Hercules, CA), respec-
tively. Serum lipids were measured after overnight fasting as
well. Animals were sacriﬁced, and serum was isolated as
described.34 Total cholesterol, high-density lipoprotein, low-
density lipoprotein (LDL), triglycerides, and free fatty acids
were measured by Marshﬁeld Labs (Marshﬁeld Clinic,
Marshﬁeld, WI). To measure tolerance to glucose, a solution
of 50% D-glucose (2 g/kg body weight) was injected i.p., and
the blood glucose was determined 10, 20, 30, 60, 90, 120, and
150 minutes after the injection.
Statistical Analysis
All images are representative of studies in three to ﬁve animals
per genotype. The quantitative data represent means  SEM;
the number of animals (n) is indicated in each ﬁgure. Either a
two-tailed, unpaired, Student’s t-test or the two-way repeated-
measures analysis of variance (SAS Institute, Inc., Cary, NC)
was used to determine statistical signiﬁcance, which is deﬁned
as P< 0.05, P< 0.01, and P< 0.001. The two-way repeated-
measures analysis of variance was applied to the glucose
tolerance tests and ERG recordings. The repeated measures
were the individual (in the same animal) glucose levels at
different time points or individual ERG responses to different
intensity of the ﬂash light. When analysis of variance showed
major interactions, post hoc contrasts between the same points
in different groups were performed using the t-test and then
corrected by the Bonferroni test.
Results
Altered Cholesterol Maintenance in the Cyp27a1/
Cyp46a1/ Retina
The levels of cholesterol precursors lanosterol, lathosterol,
and desmosterol (Figure 1A) were essentially unchanged in2406both sexes of Cyp27a1/Cyp46a1/ mice (Figure 1B),
with the exception of a slight, but signiﬁcant, 1.2-fold in-
crease in females for lathosterol, a marker for cholesterol
biosynthesis.35 The cholesterol metabolites and products of
CYP27A1 (27-hydroxycholesterol and 5-cholestenoic acid)
were not detected in the Cyp27a1/Cyp46a1/ retina
(Figure 1C), because they were not detected in the
Cyp27a1þ/þCyp46a1þ/þ retina, where these sterols are
lower than the limits of detection (1 pmol/mg protein) and at
much lower levels than the levels of 27-hydroxycholesterol
and 5-cholestenoic acid in human retina.10 These interspe-
cies differences could be due to a much shorter death-
to-tissue preservation time (<1 hour for mouse retinas and
approximately 12 hours for human retinas) preventing sterol
accumulation due to arrested blood ﬂow. Alternatively, there
may be enzymes in mouse, but not human, retina that act on
these products, also reducing the steady-state levels of
CYP27A1 metabolites in mice. The product of CYP46A1
(24-hydroxycholesterol) was not detected in the Cyp27a1/
Cyp46a1/ retina (Figure 1C), consistent with the absence
of this metabolic pathway. Pregnenolone, a product of
CYP11A1, was not detected either. Thus, abolished choles-
terol metabolism via CYP27A1 and CYP46A1 was not
compensated by either increased metabolism by CYP11A1
or reduction in cholesterol biosynthesis. The levels of unes-
teriﬁed cholesterol (UC) were unchanged in Cyp27a1/
Cyp46a1/ females and were decreased 1.7-fold in males
compared with the sex-matched Cyp27a1þ/þCyp46a1þ/þ
littermates (Figure 1D). This could reﬂect a reduced uptake of
blood-borne cholesterol, increased cholesterol elimination
via lipoprotein-mediated transport, and/or increased choles-
terol esteriﬁcation to store sterol excess in intracellular lipid
droplets. The latter possibility was tested by the measure-
ments of total (unesteriﬁed plus esteriﬁed) retinal cholesterol.
The levels of total cholesterol were increased 1.8- and 2-fold
in Cyp27a1/Cyp46a1/ females and males, respectively
(Figure 1D), thus indicating that when retinal cholesterol
metabolism is abolished, cholesterol is accumulated in the
retina and begins to be esteriﬁed.
We measured retinal cholestanol, a hallmark sterol
accumulating along with cholesterol in the form of xan-
thomas in tendons and brain of patients with CYP27A1
deﬁciency.36 Xanthomas are absent in Cyp27a1/ mice,
despite increased sterol levels in the plasma, tendons, and
brain.37 Retinal cholestanol levels were increased 10-fold in
Cyp27a1/Cyp46a1/ females and 5-fold in Cyp27a1/
Cyp46a1/ males (Figure 1E), prompting the measure-
ments of cholestanol in the retinas of Cyp27a1/ and
Cyp46a1/ mice. In both genotypes, cholestanol was
altered only slightly, compared with their wild-type litter-
mates (Figure 1E). Thus, a greater than ﬁvefold increase in
cholestanol seems to be a distinct feature of the Cyp27a1/
Cyp46a1/ retina.
We next investigated the distribution of the unesteriﬁed
retinal sterols by staining with the ﬂuorescent compound ﬁli-
pin interacting with the sterol 3b-hydroxyl group.38 UC is theajp.amjpathol.org - The American Journal of Pathology
Phenotype of Cyp27a1/Cyp46a1/ Micemajor retinal sterol39 and the sterol present at approximately
eightfold higher levels than unesteriﬁed cholestanol in tendon
xanthomas in CYP27A1-deﬁcient people.40 Accordingly, ﬁl-
ipin staining in the Cyp27a1/Cyp46a1/ retinas most
likely reﬂects the distribution of UC. Overall, histochemistry
with ﬁlipin was similar in the Cyp27a1/Cyp46a1/ and
Cyp27a1þ/þCyp46a1þ/þ retinas, except that a distinct ﬂuo-
rescent line was observed in the wall of many intraretinal
blood vessels (Figure 2, B and C), suggesting sterol accumu-
lation. In addition, the Cyp27a1/Cyp46a1/ retinas had
intense focal ﬂuorescent signals at the apical and basal sides of
the RPE (Figure 2, B and C) and labeling of the lumen of some
of the choroidal vessels (Figure 2B). Deposits at the basal
aspect of the RPE were also detected by TEM (Figure 2E),
although their composition was not investigated. Deposit-
containing RPE cells had increased granule (eitherFigure 1 Altered sterol proﬁle in the Cyp27a1/Cyp46a1/ retina. A: A simpliﬁ
the sterols quantiﬁed in BeF. Quantiﬁcation of lanosterol, lathosterol, and desmoste
the bile acid intermediate 7a-hydroxy-4-cholesten-3-one (E); and 7-ketocholesterol
samples (nZ 40 per sex per genotype); error bars indicate SEM and represent technica
background (C57BL/6J;129S6/SvEv) different from that of Cyp27a1/mice (C57BL/
Hatched bars indicate knockout mice while solid ﬁll represents wild type. *P< 0.05, *
oxidation; 24-OH, 24(S)-hydroxycholesterol; 27-COOH, 5-cholestenoic acid; 27-OH, 2
mice; SKO2, Cyp27a1/ mice; WT, Cyp27a1þ/þCyp46a1þ/þ mice.
The American Journal of Pathology - ajp.amjpathol.orgmelanosomes or lipofuscin) formation, which could lead to the
RPE dysfunction.41,42
Finally, we investigated retinal expression of cholesterol-
related genes. Only male mice were analyzed, because they
had more pronounced changes of total retinal cholesterol than
females. We used a PCR array to proﬁle 84 genes from the
pathways of cholesterol synthesis, uptake, intracellular pro-
cessing, trafﬁcking, storage, metabolism, efﬂux, and regula-
tion (Supplemental Table S1 and Supplemental Figure S1). Of
these, only three (Cyp46a1, Akr1d1, and Cela3b) showed a
greater than twofold change in expression (an arbitrary cutoff
limit) in the Cyp27a1/Cyp46a1/ compared with the
Cyp27a1þ/þCyp46a1þ/þ retina. mRNA levels of cholesterol-
esterifying enzymes sterol O-acyltransferase (SOAT)1 and
SOAT2 were unaltered, consistent with the primarily trans-
lational and post-translational, but not transcriptional,ed scheme of cholesterol biosynthesis and initial steps of metabolism showing
rol (B); 24-OH and pregnenolone (C); cholesterol (D); cholestanol, a product of
(F). The results are the means of triplicate measurements of the pooled retinal
l variability. Because Cyp46a1/ and Cyp27a1/Cyp46a1/mice were on a
6J), sterols in WT mice were measured in animals on two different background.
*P< 0.01, and ***P< 0.001. 7-Ketocholesterol, a product of cholesterol auto-
7-hydroxycholesterol; DKO, Cyp27a1/Cyp46a1/ mice; SKO1, Cyp46a1/
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Saadane et almechanisms of regulation of SOAT1, the major enzyme
esterifying cholesterol.43 Changes in the expression of
Cyp46a1, Akr1d1, and Cela3bwere conﬁrmed by quantitative
real-time PCR (qPCR). A 17.7-fold down-regulation of the
nonfunctional Cyp46a1 gene should not lead to metabolic
consequences in Cyp27a1/Cyp46a1/ mice. A 3.6-fold
up-regulation of Akr1d1 is probably a part of a mechanism
leading to increased retinal cholestanol levels because Akr1d1
encodes D4-3-ketosteroid-5b-reductase, which metabolizes
7a-hydroxy-4-cholesten-3-one, a cholestanol precursor pro-
duced by the liver and known to ﬂux in the brain across the
blood-brain barrier in Cyp27a1/ mice.37,44 A similar
mechanism could be operative in the retina of Cyp27a1/
Cyp46a1/ mice. A 2.5-fold increase in retinal levels of
Cela3b, encoding a serine protease elastase-3B and mainly
expressed in the pancreas, was less understandable and
investigated further. Normally, elastase-3B is secreted from
the pancreas into the small intestine, where it becomes acti-
vated and participates in protein digestion.45 During pancrea-
titis, however, elastase-3B is released in the blood, causing
microvascular leakage and neutrophilic inﬂammation in
distant organs.46 To test for pancreatitis in Cyp27a1/Figure 2 Sterol deposition in the retina and choroid of Cyp27a1/Cyp46a1/
Cyp46a1þ/þ retina (A) and different areas of a representative Cyp27a1/Cyp46a1
C. White arrowheads point to sterol deposits in the vascular wall. TEM of represe
White arrows point to granules (either melanosomes or lipofuscin). White dashed
Ch, choroid; GCL, ganglion cell layer; OPL, outer plexiform layer; RPE, retinal pig
2408Cyp46a1/ mice, we assessed pancreatic expression of
Cela3b and two proinﬂammatory genes, Tnfa and Il6, as
markers of inﬂammation. The pancreatic Cela3b levels were
sevenfold higher inCyp27a1/Cyp46a1/ thanCyp27a1þ/þ
Cyp46a1þ/þ mice, but the Tnfa and Il6 levels were decreased,
5- and 2.5-fold, respectively, indicating a lack of inﬂammation.
An increased pancreatic expression of elastase-3B, which binds
cholesterol and has been suggested to be involved in the in-
testinal transport of cholesterol,47 could represent a body’s
compensatory response to a decreased cholesterol solubilization
in the intestine due to a decreased production of bile acids as a
result of CYP27A1 deﬁciency. Similarly, elastase-3B could be
involved in transport of cholesterol in the retina and become up-
regulated in Cyp27a1/Cyp46a1/ mice because of the
accumulation of retinal cholesterol.
Pathological Features in the Cyp27a1/Cyp46a1/
Retina
In vivo examination of mice by SD-OCT revealed multiple
bilateral hyperreﬂective spots that were localized throughout
the Cyp27a1/Cyp46a1/ retina (Figure 3, A and D).mice. Detection of UC with ﬁlipin (in cyan) in a representative Cyp27a1þ/þ
/ retina (B and C). Colored boxes represent enlarged regions of A, B, and
ntative Cyp27a1þ/þCyp46a1þ/þ (D) and Cyp27a1/Cyp46a1/ (E) mice.
line in E outlines the deposit. Scale bars: 100 mm (AeC); 2 mm (D and E).
ment epithelium.
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Phenotype of Cyp27a1/Cyp46a1/ MiceMales had more spots than females (90% versus 75% at 3
months of age) (Supplemental Figure S2A), consistent with a
higher level of their total retinal cholesterol. When examined
in cross section, the areas of increased light reﬂection repre-
sented hyperreﬂective whorl-like structures at the interface
between the outer plexiform layer (OPL) and the outer nuclear
layer (ONL) as well as disturbances in the PR ISs (Figure 3B).
These abnormalities (conﬁrmed by histological examination)
(Supplemental Figure S2C) did not resolve with age, and
instead often increased in size (Figure 3E). In some cases, they
coalesced to form a patent RCA, as indicated by the Doppler
ﬂow of SD-OCT (Figure 3F). The Cyp27a1þ/þCyp46a1þ/þ
littermates also had hyperreﬂective spots on SD-OCT
(Figure 3G). However, these spots were observed only at
the OPL/ONL interface (Figure 3H and Supplemental
Figure S2C), were less frequent and much smaller than in
Cyp27a1/Cyp46a1/ mice (Supplemental Figure S2A
and Figure 3H), and did not grow with age. These spots
probably represented the manifestation of the naturally
occurring mutation in the crumbs homolog 1 gene (Crb1rd8),
which is present in mouse strain C57BL/6N from common
commercial vendors andwhich leads to speciﬁc retinal lesions
when homozygous.48,49 In our colony, 80% and 15% of
Cyp27a1/Cyp46a1/mice and their matchingCyp27a1þ/þ
Cyp46a1þ/þ littermates were homozygous and heterozygous
for Crb1rd8, respectively, whereas 5% lacked this mutation.The American Journal of Pathology - ajp.amjpathol.orgDespite the high prevalence of the Crb1rd8 allele in our colony,
only modest Crb1rd8-related lesions were observed compared
with the reported manifestation of this allele in C57BL/6N
mice.48e50 This may reﬂect a background effect, because our
animals were on a mixed C57BL/6J;129S6/SvEv background,
and the C57BL/6J background is known to suppress the
Crb1rd8 phenotype.51,52 To control for possible contributions of
the Crb1rd8 mutation to the pathological phenotype, we only
made comparisons betweenCyp27a1/Cyp46a1/mice and
their Cyp27a1þ/þCyp46a1þ/þ littermates.
RCAs were not the only vascular pathological feature
noted in the Cyp27a1/Cyp46a1/ retina. FA revealed
additional vascular abnormalities, none of which were
observed in Cyp27a1þ/þCyp46a1þ/þ littermates. The most
prominent lesion was the increased permeability of blood
vessels, as indicated by imaging at early, intermediate, and
late phases of FA. Vascular leakage was always observed
around the RCAs (Figure 4, FeH), with a typical RCA
pattern of ﬂuorescein hyperﬂuorescence.53 In some areas,
however, the pattern of FA was different (Figure 4, OeQ)
and did not seem to be associated with an RCA. FA also
revealed areas of vascular nonperfusion (Figure 4, JeM),
arteriovenous shunts (Figure 4, OeQ), localized vascular
deformations (Figure 4R), and focal defects (Figure 4R).
Retinal characterizations by TEM and elastase digests
provided additional ﬁndings. TEM documented a blood vesselFigure 3 Retinal abnormalities in Cyp27a1/
Cyp46a1/ mice. Representative SD-OCT fundus
depth images (50-degree ﬁeld of view) at the OPL
in the Cyp27a1/Cyp46a1/ animal (A and D)
and sex-matched Cyp27a1þ/þCyp46a1þ/þ litter-
mate (G). Areas of pathology are outlined by ovals
and circles. The areas examined in cross section
(yellow) and the newly formed lesions (green). SD-
OCT cross sections through the lesion area in the
Cyp27a1/Cyp46a1/ retina (B and E) and the
manifestation of the Crb1rd8 mutation in the
Cyp27a1þ/þCyp46a1þ/þ retina (H). Approximately
80% of Cyp27a1/Cyp46a1/ mice and match-
ing Cyp27a1þ/þCyp46a1þ/þ littermates are ho-
mozygous for Crb1rd8, approximately 15% are
heterozygous, and approximately 5% lack the
mutation. The Doppler ﬂow (C, F, and I) of B, E,
and H showing the RCA (F) and the separation of
the retinal and choroidal vascular networks (C and
I). The pattern of SD-OCT changes is similar in
males and females and between animals with a
different number of hyperreﬂective spots. Scale
bars: 300 mm (A, D, and G); 100 mm (B, C, E, F, H,
and I). Ch, choroid; GCL, ganglion cell layer; IPL,
inner plexiform layer; mo, months; ONL, outer
nuclear layer; OPL, outer plexiform layer; RPE,
retinal pigment epithelium; SD-OCT, spectral-
domain optical coherence tomography.
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Saadane et alprotruding into the normally avascular RPE in theCyp27a1/
Cyp46a1/ retina and showed thickening of the basement
membrane in this anastomosing blood vessel (Figure 4N).
Basal membrane infoldings were lost in affected RPE cells,
likely impairing their absorption and secretion. The elastase
digests revealed retinal capillary degeneration, hypercellular
blood vessels (dilated and nondilated), areas of condensedFigure 4 Different types of vascular abnormalities in the Cyp27a1/Cyp46a1
and the vascular leakage (arrows of the same color indicate the same lesion) of C
(50-degree ﬁeld of view) (D and I). TEM of the retinal cross section through th
umenting a blood vessel in the RPE (yellow oval) and no membrane infoldings (
abnormalities in Cyp27a1/Cyp46a1/ mice (JeM and OeR); vascular nonperfu
(J and OeQ); and vascular deformations (gray arrow) and focal defects (red cir
dilated hypercellular blood vessels (green oval and blue circles, respectively, in
circles, respectively, in T); intraretinal microvascular abnormality consisting o
degenerated capillaries (magenta arrows in U; green arrows point to normal capil
mm (SeU). RPE, retinal pigment epithelium; SD-OCT, spectral-domain optical coh
2410retinal vasculature, and areas containing membrane sheets
(Figure 4, T and U). Thus, ablation of retinal cholesterol
metabolism leads to pronounced effects on retinal vascula-
tures, with features shared with type 3 neovascular AMD
(RCAs) and also diabetic retinopathy (vascular nonperfusion,
capillary degeneration, increased vascular permeability, and
thickening of the vascular basement membrane).54e56/ retina. Fluorescein angiography (FA) of Cyp27a1þ/þCyp46a1þ/þ (AeC)
yp27a1/Cyp46a1/ mice (FeH, JeM, and OeR). SD-OCT fundus images
e representative lesion (yellow arrow in FeI) with vascular leakage doc-
blue arrow in E) (N). Representative FA images of other types of vascular
sion (white ovals and circle) (JeM); arteriovenous shunts (fuchsia ovals)
cle) (R). Retinal analyses by elastase digests (SeU) show nondilated and
T); membrane sheets with and without pigment (solid and dashed black
f hypercellular condensed retinal vasculature (orange circle in U); and
laries). Scale bars: 100 mm (AeC, FeH, JeM, and OeR); 2 mm (E and N); 50
erence tomography.
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Phenotype of Cyp27a1/Cyp46a1/ MiceTo test whether increased permeability of retinal blood
vessels is associated with a leakage of lipids, retinal cross
sections were stained with oil red O, an oil-soluble dye that
labels tissue deposits of fat. The Cyp27a1/Cyp46a1/
retinas had localized areas of intense ruby color (Figure 5A),
whereas the Cyp27a1þ/þCyp46a1þ/þ retinal layers had faint
and uniform oil red O staining (Figure 5K). The oil red
Oestained spots in theCyp27a1/Cyp46a1/ retinas varied
in size and location and were present in the normally vascular
GCL and INL as well as in the normally avascular ONL and
PR. These sections were then restained with tomato lectin,
which labels blood vessels, microglia, and sometimes
PRs.57,58 The lectin signals were larger and more intense in the
Cyp27a1/Cyp46a1/ than in the Cyp27a1þ/þCyp46a1þ/þ
retinas (Figure 5, B, G, and L), suggesting blood vessel dila-
tion and microglia activation. In some cases, the lectin staining
colocalized with the areas of intense oil red O staining
(Figure 5, C and H). TEM imaging conﬁrmed lipid leakage
from the Cyp27a1/Cyp46a1/ retinal vasculature by
demonstrating lipid deposition inside and adjacent to blood
vessels (Figure 5D). In contrast, no lipid accumulations were
noted in the blood vessels of the systemic circulation, as
indicated by the oil red O staining of the aortic root of the heart
(Figure 5J), a preferred site for the atherosclerotic lesion for-
mation in mice.33 In the Cyp27a1/Cyp46a1/ retina, lipid
droplets were also noted in the intraretinal space away fromFigure 5 Focal lipid accumulation in the Cyp27a1/Cyp46a1/ retina. Repre
Cyp27a1/Cyp46a1/ retina (AeC) and the corresponding region in the Cyp27aþ
staining of the cross sections through the aortic root of the heart in the Cyp27a1/
boxed regions in AeC (FeH). TEM of the Cyp27a1/Cyp46a1/ retina conﬁrm l
respectively, in D), away from blood vessels (orange arrows, E), and in the RPE (mag
E); 1 mm (I). INL, inner nuclear layer; ONL, outer nuclear layer; OPL, outer plexifo
The American Journal of Pathology - ajp.amjpathol.orgblood vessels (Figure 5E) and in the RPE (Figure 5I), where
they contained multilamellar circular structures resembling
myelin ﬁgures, which are typically connected to a reservoir of
dense lipid plaques.59 The presence of lipid droplets at loca-
tions away from blood vessels suggests that their accumulation
is the result of the dysfunctional cholesterol metabolism rather
than increased permeability of blood vessels. Thus, lipid
accumulation in the Cyp27a1/Cyp46a1/ retina seems to
occur via two processes, vascular abnormalities and metabolic
changes.
To examine overall retinal function, ERGs were recorded
under dark- and light-adapted conditions from 3- and 6-
month-old mice (Supplemental Figure S3). Dark-adapted
(scotopic) ERGs of 3-month-old Cyp27a1/Cyp46a1/
female and male mice were not signiﬁcantly different from
those of Cyp27a1þ/þCyp46a1þ/þ controls. Light-adapted
(photopic) ERGs were also comparable at this age. When
examined at 6 months of age, dark-adapted ERGs of
Cyp27a1/Cyp46a1/ mice were reduced lower than
those of controls for both females and males. The amplitude
reductions were statistically signiﬁcant for males, consistent
with the higher frequency of lesions in the males in com-
parison to the females. This sex-speciﬁc difference was also
seen in light-adapted (photopic) ERGs, where in comparison
to controls, cone ERGs of only males were signiﬁcantly
reduced in amplitude.sentative staining of the cross section through the area of pathology in the
/þCyp46a1þ/þ retina (KeM). N: Histological quantiﬁcations. Representative
Cyp46a1/ (J) and Cyp27a1þ/þCyp46a1þ/þ (O) mice. Enlarged view of the
ipid deposition inside and outside blood vessels (white and yellow arrows,
enta arrow, I). Scale bars: 100 mm (AeC, FeH, J, KeM, and O); 2 mm (D and
rm layer; PR, photoreceptor; RPE, retinal pigment epithelium.
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Deﬁciency
The retinal abnormalities in Cyp27a1/Cyp46a1/ mice
prompted us to evaluate nonocular organs to determinewhether
these changes reﬂect a system phenotype. Visual inspection of
Cyp27a1/Cyp46a1/ animals revealed that they were lean
and had an altered appearance of three nonocular systems:Figure 6 Nonocular manifestations of Cyp27a1/Cyp46a1/ deﬁciency. Inc
as indicated by histochemistry and quantitative measurements (F and G). I: The liv
of brown adipose tissue (BAT) is decreased. The lung Abcg1 levels (C), total body
(FFAs; K), fasting blood glucose (L), and hemoglobin A1c (N) are unchanged in Cy
**P < 0.01, ***P < 0.001. Scale bar Z 100 mm (A, B, D, and E).
2412lungs, liver, and spleen (Figure 6 and Supplemental Figure S4).
The lungs had a milky appearance in both Cyp27a1/
Cyp46a1/ males and females, likely due to focal accumula-
tion of neutral lipids mainly present in perivascular regions
(Figure 6B). The color of the Cyp27a1/Cyp46a1/ liver
was also milky in both sexes (Supplemental Figure S4B),
consistent with a signiﬁcant increase in the amount of neutral
lipids and esteriﬁed cholesterol (Figure 6, EeG). Lipidreased content of neutral lipids in the lungs (A and B) and livers (D and E),
er weight is increased in Cyp27a1/Cyp46a1/ mice, whereas the amount
weight (H), serum lipids (TC, total cholesterol) (J), serum free fatty acids
p27a1/Cyp46a1/ mice; however, tolerance to glucose (M) is improved.
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Phenotype of Cyp27a1/Cyp46a1/ Miceaccumulation could contribute to the liver enlargement noted in
Cyp27a1/Cyp46a1/ mice. There was a trend toward in-
creased spleen weight in Cyp27a1/Cyp46a1/ males
(Figure 6I), and a statistically signiﬁcant increase in the organ
weight in Cyp27a1/Cyp46a1/ females older than 13
months (Supplemental Figure S4D). The amount of total body
fat was reduced in both Cyp27a1/Cyp46a1/ sexes, as in-
dicated by the measurements of the interscapular brown fat, yet
the bodyweightwas unchanged comparedwith theCyp27a1þ/þ
Cyp46a1þ/þ mice (Figure 6, H and I, and Supplemental
Figure S4C). Despite changes in the lungs, liver, and amount
of fat, the levels of serum lipids, free fatty acids, glucose, and
hemoglobin A1c (an indicator of a long-term blood sugar con-
trol) were essentially unchanged in Cyp27a1/Cyp46a1/
mice of both sexes compared with Cyp27a1þ/þCyp46a1þ/þ
animals (Figure 6, L and N); Cyp27a1/Cyp46a1/ mice
even showed an improved tolerance to glucose (Figure 6M).
Overall, serum analyses demonstrated that the abnormalities
noted in the Cyp27a1/Cyp46a1/ retina were unlikely due
to an altered chemistry in the systemic circulation. Hence, we
focused on the retina again and investigated some of the pro-
cesses that could be triggered by cholesterol accumulation and
impaired production of oxysterols.
Immune Response of the Cyp27a1/Cyp46a1/ Retina
The formation of abnormal anastomosing blood vessels
motivated retinal evaluations by the angiogenesis PCR array,Figure 7 Macrophages/microglia activation in the Cyp27a1/Cyp46a1/ ret
retinal cross sections for Iba1 (E and F) and GFAP (G and H). Corresponding images
Nuclei were stained with Hoechst (B, D, K, and M) or DAPI (EeH and NeQ). Cont
Scale bar Z 100 mm (EeH and NeQ). GCL, ganglion cell layer; INL, inner nucl
plexiform layer; RPE, retinal pigment epithelium.
The American Journal of Pathology - ajp.amjpathol.orgwhich proﬁles a diverse set of genes associated with patho-
logical neovascularization (Supplemental Table S2 and
Supplemental Figure S1). Of the 84 genes evaluated, the
expression levels of only four were up-regulated by twofold in
the Cyp27a1/Cyp46a1/ retinas in comparison to the
Cyp27a1þ/þCyp46a1þ/þ retinas. These included the genes
encoding proinﬂammatory cytokine Tnfa, chemokines Ccl2
and Cxcl2, and the receptor for the ﬁbroblast growth hormone
(Fgfr3). RT-qPCR validated the PCR array data and demon-
strated that the increases in the gene expression are moderate
(up to 6.5-fold) in the Cyp27a1/Cyp46a1/ retinas, sug-
gesting that either the up-regulation of proinﬂammatory genes
occurs only in speciﬁc retinal cells or that the inﬂammation is
of a low grade.
Macrophages constitute a cell type where proinﬂammatory
genes could be up-regulated by deﬁciency of CYP27A1 and
CYP46A1, because oxysterols activate LXRs inmacrophages,
and synthetic LXR agonists suppress a set of inﬂammatory
genes in these cell types.60 To pursue this idea, retinal ﬂat
mounts were treated with antibodies against F4/80, and retinal
cross sections were stained for Iba1, two different markers
for macrophageal/microglial activation.61 At the level of the
inner retina, the Cyp27a1/Cyp46a1/ ﬂat mounts showed
F4/80-positive cells, which had stout cell bodies and thick cell
processes (Figure 7, A and B), indicative of macrophage
activation. There was also faint anti-F4/80 staining at the level
of the outer retina (Figure 7, C andD). Anti-F4/80 stainingwas
not detected in either the inner or outer retina of Cyp27a1þ/þina. Representative staining of the retinal ﬂat mounts for F4/80 (AeD) and
for a Cyp27a1þ/þCyp46a1þ/þ mouse (JeQ). I: Histological quantiﬁcations.
rol sections (Ctrl) were treated with the serum from nonimmunized animals.
ear layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer
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Saadane et alCyp46a1þ/þmice (Figure 7, JeM). Anti-Iba1 signal in retinal
cross sections conﬁrmed an increased number of macrophage/
microglial cells in the Cyp27a1/Cyp46a1/ inner retina
and revealed microglia/macrophage migration to the
subretinal space (Figure 7F). Iba1 labeling in the ONL and
subretinal space is not usually observed in pigmented mice61
and was not noted in Cyp27a1þ/þCyp46a1þ/þ littermates
(Figure 7O).
This evidence of activated macrophage/microglial cells
led us to stain for CD11b, the aM subunit of the aMb2
integrin, an adhesion receptor expressed on the surface of
monocytes (precursors of macrophages in the blood) and
other leukocytes.62 Anti-CD11b signal was elevated inside
retinal blood vessels of Cyp27a1/Cyp46a1/ mice
(Figure 8, B and U), suggesting the activation of theFigure 8 Increased inﬂammatory response and oxidative stress in the Cyp2
(CD11b) (A and B), complement factors C3/C3a and C9 (CeF), iso[4]levuglandin E
for a Cyp27a1þ/þCyp46a1þ/þ mouse (GeL and QeT). Control sections (Ctrl) wer
rounded rectangles indicate increased staining compared with the Cyp27a1þ/þC
antibody binding to both esteriﬁed and unesteriﬁed forms of the sterol, whereas
Histological quantiﬁcations. Scale barZ 100 mm (AeT). GCL, ganglion cell layer;
outer nuclear layer; OPL, outer plexiform layer; RPE, retinal pigment epithelium.
2414receptor-containing cells or more leukocytes in blood. When
activated, the aMb2-containing blood cells usually adhere to
the vascular endothelium, which triggers various events,
including inﬂammation and increased production of reactive
oxygen species.62,63 Hence, we next stained for C3 and C3a.
C3 is central to all complement activation pathways, and
C3a is an anaphylatoxin and mediator of local inﬂammatory
responses.64 Increased expression of C3 in mouse retina has
been shown to lead to signiﬁcantly increased vascular
permeability.65 Consistent with the abnormal blood vessel
leakage in the Cyp27a1/Cyp46a1/ retina, an anti-C3/
C3a signal was detected and was mostly associated with
blood vessels (Figure 8D). We next stained the retina for
complement factor C9, an indicator of the assembly of the
terminal membrane attack complex, which disrupts the7a1/Cyp46a1/ retina. Representative stainings for the aMb2 integrin
2 (M and N), and 7-ketocholesterol (7-keto; O and P). Corresponding images
e treated with the serum from nonimmunized animals. White arrows and
yp46a1þ/þ retinas. Immunostaining for 7-ketocholesterol likely represents
the measurements in Figure 1 are of unesteriﬁed 7-ketocholesterol only. U:
INL, inner nuclear layer; IPL, inner plexiform layer; IS, inner segment; ONL,
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Phenotype of Cyp27a1/Cyp46a1/ Micetarget cell membranes and leads to cell lysis.66 C9 staining
was also increased in the Cyp27a1/Cyp46a1/ retina,
where it was mainly restricted to blood vessels (Figure 8F).
Müller cells, the predominant glial cells of the retina,
contribute to the blood-retinal barrier. Hence, pathological
processes in retinal vasculature in Cyp27a1/Cyp46a1/
mice could lead to activation of Müller cells or vice versa. The
retina was stained for glial ﬁbrillary acidic protein (GFAP), an
intermediate ﬁlament protein up-regulated in Müller cells in
response to different insults.67 Anti-GFAP immunoreactivity
was detected everywhere in Cyp27a1/Cyp46a1/, but not
Cyp27a1þ/þCyp46a1þ/þ, retinas (Figure 7, H and Q) and was
primarily localized to the GCL, the major site for the GFAP
immunoreactivity in Müller cells,68 which span the entire
thickness of the retina. Faint, punctate staining was also present
in the INL containing Müller somas, the normally avascular
ONL, and also in the RPE, resembling a staining pattern re-
ported in patients with AMD.69 In the areas of vascular ab-
normalities, GFAP staining was more pronounced and
encompassed longer regions of the Müller cells.
Oxidative stress is a common factor that could lead to the
activation ofmacrophages andMüller cells.67,70 The presence
of this pathological process in the Cyp27a1/Cyp46a1/
retina was assessed by staining for two lipids: isolevuglandins
(isoLGs) and 7-ketocholesterol, oxidation products of
arachidonate and cholesterol, respectively.71,72 Adducts of
isoLGs with proteins and phospholipids serve as long-term
biomarkers of oxidative stress, and are found at increased
concentrations in plasma and vasculature of patients with
atherosclerosis and in plasma of patients with AMD.73,74 7-
Ketocholesterol is a proinﬂammatory and pro-apoptotic
oxysterol produced nonenzymatically from cholesterol andThe American Journal of Pathology - ajp.amjpathol.orgshown to induce inﬂammation and angiogenesis in vivo.75
The isoLG signal was detected inside the blood vessels of
theGCL inboth theCyp27a1/Cyp46a1/ andCyp27a1þ/þ
Cyp46a1þ/þ retinas, but was much higher in the Cyp27a1/
Cyp46a1/ retina (Figure 8, M, N, Q, and R). This staining,
along with that for CD11b, is in agreement with previous
studies showing that isoLGs can modify plasma LDL and be
recognized by macrophages.76,77 TheCyp27a1/Cyp46a1/
retina also had a much stronger isoLG signal in the ISs, where
light-induced oxidative stress leads to the formation of isoLGs
and alterations ofmitochondrial morphological features.31 The
pattern of staining for 7-ketocholesterol was different, because
the signal was only associated with the wall of retinal blood
vessels and was present only inCyp27a1/Cyp46a1/mice
(Figure 8,O, P, S, andT). IsoLG and 7-ketocholesterol staining
documented elevated oxidative stress in speciﬁc regions of the
Cyp27a1/Cyp46a1/ retina.
Discussion
Our major ﬁndings are that global ablation of Cyp27a1/
and Cyp46a1/ in mice leads to retinal microangiopathy
(Figure 4) and changes in several nonocular organs
(Figure 6), but does not affect systemic lipid and glucose
levels (Figure 6). Pathological processes identiﬁed in retinal
blood vessels of Cyp27a1/Cyp46a1/ mice ﬁt remark-
ably well the scenario of atherosclerosis,70 although the
retina contains only small arterioles instead of arteries.
Therefore, in suggesting the putative sequence of early
events ultimately leading to vascular lesions in the
Cyp27a1/Cyp46a1/ retina (Figure 9), we used the
current knowledge of atherosclerosis.Figure 9 Proposed pathological events in the
Cyp27a1/Cyp46a1/ retina. The sequence of
events is numbered chronologically with primes
(0,0 0), indicating events that may occur simulta-
neously, because CYP27A1 and CYP46A1 may have
dual roles [eg, metabolic (green) and regulatory
(blue) roles], and one event may trigger several
parallel events. Events in magenta are suggested
to play key roles in the proposed sequence. Gray
indicates events that have not been conﬁrmed
experimentally (ie, event 10, abrogation of LXR
regulation). All paths ultimately lead to the
development of vascular abnormalities (bold-
faced).
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vascular endothelium at sites with disturbed blood ﬂow and
subendothelial accumulations of lipids, usually as a result of
the elevated plasma LDL levels.70 Cyp27a1/Cyp46a1/
mice have a normolipidemic plasma proﬁle (Figure 6), but
their retinal vascular wall has sterol accumulations (Figure 2)
and vascular endothelium is probably activated (Events 1 to
3, Figure 9), like in the systemic circulation of CYP27A1-
deﬁcient humans, who have premature atherosclerosis
despite generally normal plasma cholesterol.78,79 The
atherosclerotic plaques in CYP27A1-deﬁcient individuals
contain more cholesterol than cholestanol (97.2% versus
2.8% of total sterol content), suggesting that cholesterol,
rather than cholestanol, probably accumulates in retinal
blood vessels and the choroidal network of Cyp27a1/
Cyp46a1/ mice.
When vascular endothelial cells are activated, they secrete
chemokines that interactwith receptors onmonocytes, leading
to monocyte recruitment.80 In the Cyp27a1/
Cyp46a1/ retina, leukocyte adhesion to blood vessels
(Event 4, Figure 9) is indicated by anti-CD11b staining
(Figure 8) and could play a role in vascular leakage and
capillary degeneration (Event 5, Figure 9). Thiswill be similar
to adherent leukocytes in diabetic retinopathy, which release
cytokines and reactive oxygen species that damage retinal
microvasculature and physically occlude capillaries.55
Leukocyte accumulation when cholesterol load in vascular
wall is increased also explainswhy cholesterol and other lipids
are oxidized inside retinal blood vessels (Event 50, Figure 9)
and 7-ketocholesterol and isoLGs are detected (Figure 8).
In atherosclerosis, monocyte adhesion is followed by their
inﬁltration into the subendothelial space and differentiation
into macrophages, which begin to uptake nonoxidized and
oxidized cholesterol-rich lipoprotein particles. This uptake
stimulates the production of a variety of molecules, including
inﬂammatory mediators, growth factors, and reactive oxygen
species, leading to unresolved inﬂammation and the forma-
tion of a complex lesion.70 Several of these atherosclerotic
processes probably occur in the Cyp27a1/Cyp46a1/
retinal vasculature. Monocyte inﬁltration (Event 6, Figure 9),
for example, is indicated by increased expression of Ccl2
(Supplemental Figure S1), monocyte chemoattractant pro-
tein 1, which is one of the key chemokines that regulate the
migration and inﬁltration of monocytes from the blood stream
across the vascular endothelium.81 An increase in macro-
phageal lipid uptake and macrophageal lipid concentrations
(Event 7, Figure 9) could be due to cholesterol accumulation in
the vascularwall (Event 2, Figure 9) and a lack ofCYP27A1 in
macrophages metabolizing uptaken cholesterol. In addition, a
decreased production of oxysterols (Event 10, Figure 9) could
impair cholesterol removal via the LXR-controlled efﬂux
(Events 10 and 11, Figure 9). Collectively, increased levels of
cholesterol and the presence of 7-ketocholesterol (Events 2
and 50, respectively, Figure 9), probably contribute to the
macrophage activation (Event 7, Figure 9) as indicated by F4/
80 and Iba1 staining (Figure 7). In theCyp27a1/Cyp46a1/2416retina, macrophage activation (Events 30 and 1100, Figure 9)
could be due to intracellular cholesterol accumulation and
aberrant immune response, respectively, because the LXR
suppression of inﬂammatory genes in macrophages could be
impaired. Lymphocytes from mice lacking LXRb were found
to exhibit enhanced responses to homeostatic and antigen-
driven challenges,82 and the CYP46A1 metabolite, 24-
hydroxycholesterol, was shown to suppress the activation
of macrophageal inducible nitric oxide synthase.83 The lack
of the CYP27A1 metabolite, 27-hydroxycholesterol,
is important in the Cyp27a1/Cyp46a1/ retina as well
because vascular abnormalities in these mice do not fully
overlap with those in Cyp27a1/12 or Cyp46a1/ mice
(under investigation). Impaired LXR signaling inCyp27a1/
Cyp46a1/mice is also implicated by someof their nonocular
abnormalities that mirror those reported in Lxra/b/ and
Abcg1/ (an LXR target) mice (Supplemental Table S3),
although genotype-speciﬁc manifestations are observed.
Macrophage activation in the Cyp27a1/Cyp46a1/
retina probably leads to inﬂammatory processes in both the
retina and retinal vasculature (Events 12 and 8, respectively,
Figure 9) and the development of vascular abnormalities
(Event 9, Figure 9). The inﬂammation in the retina is indicated
by the up-regulation of retinal expression of Cxcl2, a cytokine
encodingmacrophage inﬂammatory protein 2a,84 and of Tnfa,
a proinﬂammatory cytokine produced chieﬂy by the activated
macrophages (Supplemental Figure S1).85 The inﬂammation
inside the blood vessels is suggested by the activation of the
complement pathway, documented through staining for com-
plement factors C3/C3a and C9 (Figure 8). Complement factor
C3 is important in the pathogenesis of AMD, whereas the
terminal membrane attack complex, including C9, is deposited
in retinal vessels of diabetic humans and is suggested to play a
role in increased vascular permeability, leukostasis, and
apoptosis of retinal capillary cells.86,87 Our anti-C3/C3a and
anti-C9 vascular localizations are consistent with pathological
processes observed in retinal vasculature in AMD and diabetes
and explain, in part, vascular abnormalities in the Cyp27a1/
Cyp46a1/ retina. The present work, linking the activation of
retinal macrophages and retinal vascular abnormalities, is
consistent with a previous investigation demonstrating that
impaired cholesterol efﬂux in senescent macrophages pro-
motes AMD.88 Both studies, thus, emphasize the importance
of the mechanisms that eliminate cholesterol in macrophages
either via the lipoprotein pathway88 or by cholesterol-speciﬁc
enzymes (the present work). Our work also supports the pre-
viously suggested use of LXR agonists for the prevention of
neovascular AMD88 and diabetic retinopathy.89 Pharmaceu-
tical agents that increase the activity of CYP46A1 could be
another option because they were shown to stimulate the
production of 24-hydroxycholesterol in mouse brain90 and,
thus, have a potential to exert a similar effect in the retina.
PRs were recently identiﬁed as the major contributors to
diabetes-induced oxidative stress in the retina and play an
important role in the pathogenesis of diabetic retinopathy.91
Similarly, there is an increased production of reactiveajp.amjpathol.org - The American Journal of Pathology
Phenotype of Cyp27a1/Cyp46a1/ Miceoxygen species in the ISs of the Cyp27a1/Cyp46a1/
retina (Events 300 and 110, Figure 9), as indicated by anti-
isoLG staining (Figure 8). An increase in the oxidation of
polyunsaturated fatty acids in the ISs could affect PR
function31 and explain a reduction in ERG amplitudes in
Cyp27a1/Cyp46a1/ mice (Supplemental Figure S3 and
Event 13, Figure 9). Additional studies are required to
establish the contribution of the oxidative stress in the ISs to
overall oxidative stress in the retina.
In summary, we identiﬁed retinal lesions in normolipidemic
and euglycemic Cyp27a1/Cyp46a1/ mice, and compre-
hensively characterized these animals to begin to elucidate the
underlying reasons for the observed abnormalities. The data
obtained point to the activation in the retina of vascular
endothelium, monocytes/macrophages, and microglia cells
because of intracellular cholesterol overload and impaired
LXR signaling. These processes lead to oxidative stress and
low-grade, persistent inﬂammation and cause vascular ab-
normalities. The key roles of LXRs as cholesterol and oxy-
sterol sensors, which, in macrophages, help regulate the
pathways of inﬂammation and immune response, suggest that
agonists of these transcription factors should be considered for
the treatment or prevention of retinal diseases characterized by
vascular pathological conditions. Our ﬁndings highlight the
metabolic and regulatory importance of enzymatic cholesterol
elimination for normal status of retinal vasculature and
establish retinal signiﬁcance of this fundamental biological
process. Cyp27a1/Cyp46a1/ mice could serve as a plat-
form for pharmacological evaluation of LXR agonists and
agents stimulating CYP46A1.
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